Related Posts
More Posts
Any travel recommendations in December?
Where’s everyone partying tonight 💃🏻
Additional Posts in Life Sciences Consulting
Any ideas on the pay range for the US Regional Meetings Lead Amgen? I’ve been agency based for quite a long time. I have worked with Amgen previously, currently serving another pharma, but looking to make the leap to the client side. Trying to see if the pay would be worth it at this juncture.
Is IQVIA legit?
New to Fishbowl?
unlock all discussions on Fishbowl.




ZS. Brand that everyone in LS industry knows. Dedham is still an interesting shop where it’s broader parent org has positioned it to be a strong market access player if they can leverage the offerings well (ie MMIT).
As a client, ZS is one of our most frequently used market research vendor. Have not seen any engagements recently with Dedham.
As somebody who went from Dedham to ZS (soft doxx), ZS clears I fear
It might have been my timing but TDG was focused heavily on scaling with rinse and repeat projects in subniches lacking greater org structure. ZS had a much wider range of projects and better internal network I felt I could tap into. Felt like a more well rounded consultant leaving ZS than TDG. TDG could’ve grown and matured since so no major shade to them
Don't know about ZS, but unlike most of the industry, Dedham is actually thriving right now. Surpassing revenue targets quarter after quarter.
ZS dominates Sales Ops (IC, Territory Alignment, etc.) from my understanding. Every client uses them or boutique shops that have been created Ex-ZS folks. They have other offerings (not comprehensive) - Mkt Access, Commercial Analytics which is incorporates Sales Ops, etc. Dedham is strongly positioned for growth, so I am not surprised that an insider is confirming it. Industry as a whole is struggling / stagnant. Very few groups are growing.
Who?
Dedwho?